Improving Nighttime Access to Care and Treatment; Part 4-Haiti
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 10
SponsorUniversity of Florida
About this trial
Children in resource-limited settings who develop illness at night are often isolated from care, resulting in progression to an emergency. A telemedicine and medication delivery service (TMDS) is a viable healthcare delivery option to bridge the gap in nighttime care. This interrupted time series study (pre/post) will evaluate a digital clinical decision-support (dCDS) tool. The objective is to assess if the tool is associated with an improvement in guideline adherence by TMDS providers.
Eligibility criteria
Qualifiers
Children 10 years of age or younger with an acute illness
Parent/guardian contacts the TMDS in regards to the illness during hours of operation
Parental/guardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent/assent at the household from the parent/guardian and child (7yrs and older) for participants who receive a household visit.
Disqualifiers
No consent
Trial design
Treatments tested in this trial
- paper-based clinical decision support (dCDS) tool
- digital clinical decision support (dCDS) tool
Treatment groups
7,124 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Florida
Lead sponsor
Fogarty International Center of the National Institute of Health
Collaborator
Source ClinicalTrials.gov